# Accro Bioscience

**Canonical:** https://apis.io/providers/accrobioscience/  
**Website:** https://www.accropeutics.com/  
**APIs profiled:** 0

Accro Bioscience (Suzhou) Limited, trading as Accropeutics, is a clinical-stage biopharmaceutical company founded in 2017 with operations in Suzhou, China and New York. It develops small-molecule therapeutics against regulated cell death — necroptosis, pyroptosis and ferroptosis — targeting the cell-death-to-inflammation loop behind inflammatory, fibrotic, autoimmune and oncology disease. Its pipeline is led by AC-101, an oral selective RIPK2 inhibitor in Phase Ib for ulcerative colitis with FDA clearance for a Phase II multi-regional IBD study; AC-201, a TYK2/JAK1 pseudokinase inhibitor licensed to Fosun Pharma for Greater China as FXS5626; and AC-003, a RIPK1 inhibitor in Phase Ib for acute graft-versus-host disease with FDA Orphan Drug Designation. It closed a $50M Series C led by OrbiMed in May 2026. Accro Bioscience sells drug candidates, not software: it runs no developer program and publishes no API, SDK or machine-readable API contract.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-09-06 under rubric 0.19.0.

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Accrobioscience Domain Security** — no transport/DNS hardening detected

## Tags

Company, Biotechnology, Pharmaceuticals, Drug Discovery, Clinical Trials, Life Sciences, Immunology, Inflammation, Small Molecule, Regulated Cell Death

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/accrobioscience/). Scores are computed from the provider's own public artifacts under a published rubric.